Potential here is huge imo. I'm surprised market hasn't picked up on it.. even 2 years ago. Despite the approvals in Europe and increasing customers base.. not to mention diagnostic products it still remains unknown to the market. Definite takeover potential. If not huge increase in revenue, and share price is likely due to the expanded diagnostic range genetic signatures is developing.
GSS Price at posting:
32.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)